InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Monksdream PremiumMember
04/22/24 5:48 AM
profile icon
Monksdream PremiumMember
03/30/24 2:46 PM
profile icon
Monksdream PremiumMember
02/14/24 5:28 PM
profile icon
AJ Freely Free
07/28/23 8:45 AM
profile icon
magacrew2020 Free
02/28/23 6:21 PM
profile icon
subslover PremiumMember
08/12/22 8:58 AM
profile icon
JJJ54 Free
04/20/22 9:11 PM
profile icon
DarkPool Free
02/14/22 5:08 PM
profile icon
oxnous Terminated
04/24/21 10:13 PM
profile icon
casenumber Free
05/26/20 1:21 PM
profile icon
subslover PremiumMember
05/26/20 9:01 AM
profile icon
casenumber Free
01/08/20 3:20 PM
profile icon
ClayTrader Free
12/26/19 4:59 PM
profile icon
ClayTrader Free
12/24/19 2:04 PM
profile icon
whytestocks Free
12/24/19 12:49 PM
profile icon
ClayTrader Free
12/23/19 4:53 PM
profile icon
casenumber Free
12/23/19 4:47 PM
profile icon
ClayTrader Free
12/20/19 5:14 PM
profile icon
casenumber Free
12/20/19 2:35 PM
profile icon
Fat Thor Free
12/18/19 9:10 PM
profile icon
Fat Thor Free
12/18/19 3:36 PM
profile icon
casenumber Free
12/18/19 12:31 PM
profile icon
casenumber Free
12/18/19 12:24 PM
profile icon
Fat Thor Free
12/18/19 9:09 AM
profile icon
alchemytrader Free
12/18/19 9:01 AM
profile icon
Fat Thor Free
12/18/19 8:57 AM
profile icon
BoilerRoom Free
12/18/19 8:08 AM
profile icon
Widowsson32 Free
12/18/19 8:03 AM

Larimar Therapeutics Inc (LRMR) RSS Feed

Followers
21
Posters
85
Posts (Today)
0
Posts (Total)
335
Created
02/20/15
Type
Free
Moderators
Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity and hyperphagia in Prader-Willi Syndrome patients, craniopharyngioma-associated obesity, and severe obesity in the general population. Zafgen, Inc. is headquartered in Cambridge, Massachusetts.

Clinical Trials - Zafgen
http://www.zafgen.com/zafgen/clinical-trials

ZAFGEN INC

ONE BROADWAY 8TH FLOOR

CAMBRIDGE, MA 02142

Phone: 617-401-3051

Fax: NA

Web: http://www.zafgen.com/

Email: tgrazio@zafgen.com

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post